Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis.

Nathalie De CastroCorine ChazallonJean-Baptiste N'takpeIsabel TimanaRodrigo EscadaSandra WagnerEugène MessouSerge EholieNilesh BhattCelso KhosaDidier LaureillardGiang Do ChauValdilea G VelosoConstance DelaugerreXavier AnglaretJean-Michel MolinaBeatriz GrinsztejnOlivier Marcynull null

Published in: Open forum infectious diseases (2022)

In PWH with tuberculosis receiving raltegravir or efavirenz-based regimens, female sex, optimal adherence, and baseline HIV-1 RNA <100 000 copies/mL were associated with virologic success, and the number of antiretroviral tablets taken daily was a strong predictor of adherence.

Keyphrases

human immunodeficiency virus
antiretroviral therapy
hiv aids
hiv infected
hiv infected patients
hiv positive
hepatitis c virus
mycobacterium tuberculosis
pulmonary tuberculosis
physical activity
hiv testing
adipose tissue
nucleic acid